Mouse models of transforming growth factor beta impact in breast development and cancer - PubMed

Review

Mouse models of transforming growth factor beta impact in breast development and cancer

R Serra et al. Endocr Relat Cancer. 2005 Dec.

Abstract

It is now recognized that transforming growth factor beta (TGF-beta) is an important factor that regulates normal breast development as well as breast cancer. Genetically engineered mouse models have been used to determine the role and mechanism of TGF-beta action in normal development and diseases of the breast. Using these models, it has been determined that TGF-beta regulates many steps of normal mammary gland development including branching morphogenesis, functional differentiation, cell-lineage decisions, and involution. Effects of TGF-beta on normal development are mediated through signaling in both the epithelial and stromal compartments. In cancer, mouse models have indicated that TGF-beta has biphasic effects on tumor progression, acting as a tumor suppressor in early stages of cancer and promoting invasion and metastasis at later stages. In addition, TGF-beta may play a role in tumor progression through effects on the microenvironment. Recently, experiments in several mouse models have suggested that antagonism of TGF-beta signaling may provide a therapeutic target for late-stage breast cancer, blocking metastasis without detrimental side effects. In the future, genetically altered mice will be used to establish models of human breast disease providing opportunities to test strategies for disease prevention and treatment.

Similar articles

• Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.

  Bierie B, Stover DG, Abel TW, Chytil A, Gorska AE, Aakre M, Forrester E, Yang L, Wagner KU, Moses HL. Bierie B, et al. Cancer Res. 2008 Mar 15;68(6):1809-19. doi: 10.1158/0008-5472.CAN-07-5597. Cancer Res. 2008. PMID: 18339861

• Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.

  Forrester E, Chytil A, Bierie B, Aakre M, Gorska AE, Sharif-Afshar AR, Muller WJ, Moses HL. Forrester E, et al. Cancer Res. 2005 Mar 15;65(6):2296-302. doi: 10.1158/0008-5472.CAN-04-3272. Cancer Res. 2005. PMID: 15781643

• Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.

  Zhang H, Stephens LC, Kumar R. Zhang H, et al. Clin Cancer Res. 2006 Mar 1;12(5):1479-86. doi: 10.1158/1078-0432.CCR-05-1519. Clin Cancer Res. 2006. PMID: 16533771

• Disruption of the TGF-beta pathway and modeling human cancer in mice.

  Letterio JJ. Letterio JJ. Mutat Res. 2005 Aug 25;576(1-2):120-31. doi: 10.1016/j.mrfmmm.2005.03.004. Mutat Res. 2005. PMID: 15935406 Review.

• Role of transforming growth factor beta in cancer.

  Pasche B. Pasche B. J Cell Physiol. 2001 Feb;186(2):153-68. doi: 10.1002/1097-4652(200002)186:2<153::AID-JCP1016>3.0.CO;2-J. J Cell Physiol. 2001. PMID: 11169452 Review.

Cited by

• Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR).

  Tram E, Ibrahim-Zada I, Briollais L, Knight JA, Andrulis IL, Ozcelik H. Tram E, et al. Breast Cancer Res. 2011 Aug 11;13(4):R77. doi: 10.1186/bcr2926. Breast Cancer Res. 2011. PMID: 21835029 Free PMC article.

• Comparative mechanisms of branching morphogenesis in diverse systems.

  Lu P, Sternlicht MD, Werb Z. Lu P, et al. J Mammary Gland Biol Neoplasia. 2006 Oct;11(3-4):213-28. doi: 10.1007/s10911-006-9027-z. J Mammary Gland Biol Neoplasia. 2006. PMID: 17120154 Free PMC article. Review.

• Impaired redox regulation of estrogen metabolizing proteins is important determinant of human breast cancers.

  Maiti S, Nazmeen A. Maiti S, et al. Cancer Cell Int. 2019 May 15;19:111. doi: 10.1186/s12935-019-0826-x. eCollection 2019. Cancer Cell Int. 2019. PMID: 31114446 Free PMC article. Review.

• Noncanonical TGF-β signaling during mammary tumorigenesis.

  Parvani JG, Taylor MA, Schiemann WP. Parvani JG, et al. J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):127-46. doi: 10.1007/s10911-011-9207-3. Epub 2011 Mar 31. J Mammary Gland Biol Neoplasia. 2011. PMID: 21448580 Free PMC article. Review.

• PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling.

  Jarrar MH, Baranova A. Jarrar MH, et al. J Cell Mol Med. 2007 Jan-Feb;11(1):71-87. doi: 10.1111/j.1582-4934.2007.00003.x. J Cell Mol Med. 2007. PMID: 17367502 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Sheridan PubFactory

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)